More than half of risk-based accountable care organizations (ACOs) currently enrolled in the Medicare Shared Savings Program said they are likely to drop out due to the fear of paying losses resulting from the coronavirus disease 2019 (COVID-19) pandemic, according to a survey conducted by The National Association of Accountable Care Organizations.
More than half (56%) of risk-based accountable care organizations (ACOs) currently enrolled in the Medicare Shared Savings Program (MSSP) said they are likely to drop out of the program due to the fear of paying losses resulting from the coronavirus disease 2019 (COVID-19) pandemic, according to a survey conducted by The National Association of Accountable Care Organizations (NAACOS).
Of the 226 ACOs that completed the survey, nearly 60% reported they are likely to quit the program to avoid financial losses. In addition, 77% reported they are "very concerned" about COVID-19’s impact on their 2020 performance.
The MSSP program rewards ACOs for lowering spending and improving patient outcomes. It is the largest value-based payment model in Medicare, with an estimated savings of up to $3.53 billion between 2013 and 2017.
A separate NAACOS analysis found the COVID-19 pandemic could cost Medicare between $38.5 billion and $115.4 billion over the next year alone.
“When ACOs made a commitment to assume risk, they didn’t expect they’d be handling the risk of a global pandemic,” said Clif Gaus, president and CEO of NAACOS, in a press release.
Organizations are currently able to quit the program without penalty before May 31, 2020.
“Medicare’s decade-long effort to change how we pay for healthcare to better reward quality and outcomes may be lost unless Washington acts quickly to throw these providers a lifeline,” Gaus said.
Respondents completed the survey online from April 3-8. Specifically, when asked how likely an ACO would be to leave MSSP:
In March, NAACOS and other healthcare organizations asked CMS to “hold harmless” providers in alternative payment models from performance-related penalties for 2020.
“CMS has yet to adequately mitigate the costs and disruptions of the pandemic,” Gaus said, adding millions of Medicare beneficiaries would lose access to care coordination and quality improvement offered by ACOs should the organizations drop out of the program.
Disruptions in routine chronic care management, lack of in-office visits, rescheduling of elective procedures, and diversion of quality control staff to address the pandemic all contribute to ACOs’ concerns.
The survey also found 90% of ACOs report the COVID-19 pandemic will have a "significant" or "very significant" effect on their abilities to earn shared savings.
In addition, there is uncertainty on how the pandemic will affect “changes to acuity or risk scores, diminished opportunities to meet quality requirements related to preventive care, and which patients the ACO will be accountable for this year,” according to NAACOS.
As a result of the pandemic, 25% of respondents said they expect spending to increase by more than 10%, while 25% also responded they expect spending to increase between 5% and 10%. Of all the respondents, 37% selected "don’t know," which, according to NAACOS, illustrates the great uncertainty ACOs face.
“ACOs’ acceptance of financial risk did not account for a global pandemic," NAACOS concludes. "ACO providers are risking their lives treating COVID-19 patients. They should not also be required to risk their businesses, many of which are not equipped to potentially pay millions to the government for increased costs from COVID-19.”
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
The Biden administration recently launched the Global Health Security Strategy, a new effort to combat the spread of infectious diseases; lawmakers zeroed in on the risks of massive consolidation in health care during the first congressional hearing on the Change Healthcare hack; the FDA recently announced the recall of a pair of heart devices linked to numerous deaths and injuries.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen